FdaApplication
ANDA 218676
Identifiers
- fda_app_no: ANDA218676
Properties
| Property | Value |
|---|---|
| applicant_name | QUAGEN PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2026-03-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION;ORAL |
1 product